

Soft Tissue Core Biopsy Needle Market Scope:
Industry Analysis, Market Size, Growth, Trends Till
2031
Request Sample Report
The global Soft Tissue Core Biopsy Needle market is projected to experience significant growth due to increasing prevalence of cancer and rise in demand for minimally invasive diagnostic procedures. The market size is estimated to reach $XXX million by 2025, driven by technological advancements and expanding healthcare infrastructure.
◍ BD
◍ Medtronic
◍ IZI Medical
◍ Medax
◍ ARGON MEDICAL
◍ Ranfac
◍ Merit Medical
◍ INRAD
The competitive landscape of the Soft Tissue Core Biopsy Needle Market includes key players such as BD, Medtronic, IZI Medical, Medax, ARGON MEDICAL, Ranfac, Merit Medical, and INRAD. These companies offer innovative biopsy needle solutions to healthcare providers, contributing to the growth of the market.
- BD: $17.12 billion
- Medtronic: $28.91 billion
- Merit Medical: $1.16 billion
Request Sample Report
◍ Hospitals & Clinics
◍ Ambulatory Surgical Centers
◍ Others
◍ Below 10 cm ◍ 10-15 cm ◍ 15-20 cm ◍ Above 20 cm
Request Sample Report
Request Sample Report
$ X Billion USD